

Mondelez vs Colgate-Palmolive
Global snacks and confectionery leader with strong brands vs Global oral care and household products leader. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Mondelez International sells snacks and confections across dozens of countries, using its global distribution network and beloved brands like Oreo and Cadbury to push volume while raising prices faster than consumers walk away. Colgate-Palmolive sells oral care, personal care, and home cleaning products in nearly every country on earth, relying on category leadership and a relentless focus on emerging market growth to sustain its premium valuation. Both are classic consumer staples multinationals that use pricing power and distribution advantages to generate steady earnings growth through economic cycles. Mondelez vs Colgate-Palmolive pits two global consumer giants against each other on organic revenue growth, margin expansion potential, dividend history, and which company has the stronger runway to compound earnings from its emerging market exposure over the next decade.
Mondelez International sells snacks and confections across dozens of countries, using its global distribution network and beloved brands like Oreo and Cadbury to push volume while raising prices faste...
Why It’s Moving

Mondelez stays in a holding pattern as analysts lean positive but fresh catalysts remain limited
- Analysts remain broadly constructive on Mondelez, with most coverage still clustered around a Buy-style rating, which has helped keep sentiment anchored despite a fairly tight valuation range.
- Recent price-target updates have been modest rather than dramatic, suggesting investors are focused more on steady execution and earnings durability than on a major re-rating story.
- With no major fresh company-specific catalyst in the last week, the stock’s tone is being shaped more by the broader staples backdrop, where defensive demand and margin discipline continue to matter most.

Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.

Mondelez stays in a holding pattern as analysts lean positive but fresh catalysts remain limited
- Analysts remain broadly constructive on Mondelez, with most coverage still clustered around a Buy-style rating, which has helped keep sentiment anchored despite a fairly tight valuation range.
- Recent price-target updates have been modest rather than dramatic, suggesting investors are focused more on steady execution and earnings durability than on a major re-rating story.
- With no major fresh company-specific catalyst in the last week, the stock’s tone is being shaped more by the broader staples backdrop, where defensive demand and margin discipline continue to matter most.

Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.
- Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
- The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
- Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.
Investment Analysis

Mondelez
MDLZ
Pros
- Mondelez has strong pricing power and strategic cost controls, including efficient cocoa sourcing adjustments to manage tariff impacts.
- It is positioned for sustained long-term growth by expanding in emerging markets and shifting towards healthier product options.
- The company has scale advantages that support profitability even amid commodity cost volatility and inflation pressures.
Considerations
- Recent Q3 2025 results showed a revenue shortfall and margin pressure from historically high cocoa costs, causing a negative market reaction.
- Its stock price has declined significantly over the past year, reflecting concerns about ongoing cost inflation and macroeconomic risks.
- Sensitivity to commodity and tariff fluctuations poses risks to supply chain stability and profit margins, creating uncertainty.
Pros
- Colgate-Palmolive maintains a broad, well-established global brand presence with a diversified product portfolio in oral care and personal products.
- The company benefits from relatively stable demand and less commodity cost volatility compared to food-focused peers.
- It has demonstrated consistent profitability with efficient cost management and resilient cash flow generation.
Considerations
- Colgate-Palmolive has experienced stock underperformance compared to peers, impacted by modest organic growth challenges.
- Growth prospects may be limited by mature market exposure and competitive intensity in key categories like oral care.
- The company faces execution risks related to innovation pace and evolving consumer preferences in a crowded personal care market.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.
Buy MDLZ or CL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


